Skip to main content

Insight Molecular Diagnostics Inc.

IMDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0001642380

No open-market purchases or sales by Insight Molecular Diagnostics Inc. insiders were filed in the last 90 days; 40 institutions reported holding it in 13F filings for Q2 2026, worth $108.9M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Insight Molecular Diagnostics Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of IMDX: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders4730−17
SharesConverted for a 1-for-20 split4.59M4.55M−39.1K (−0.9%)
Value$21.1M$14.3M−$6.79M (−32.1%)

New holders (4)

Institutions that held Insight Molecular Diagnostics Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to IMDX in Q3 2023
InstitutionSharesValue% of portfolio
Comerica Bank37$1160.00%
Qube Research & Technologies Ltd1$30.00%
NBC Securities, Inc.150$00.00%
Capital Advisors, Ltd. LLC61$00.00%

Sold out (21)

Institutions that held Insight Molecular Diagnostics Inc. at the end of Q2 2023 and filed for Q3 2023 without it.